Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Vessl Therapeutics

Request full access

Innovative vascular grafts enhancing hemodialysis outcomes and reducing complications for ESRD patients

Yokneam Ilit, IsraelFounded 2000Biotech & Life Sciences

About Vessl Therapeutics

Vessl Therapy focuses on developing advanced vascular grafts to improve the quality of life for patients with end-stage renal disease (ESRD) who rely on hemodialysis. Serving a critical need in the healthcare market, Vessl Therapy targets patients who undergo mechanical blood cleaning several times a week due to the unavailability of donor kidneys. The company operates in the medical technology sector, leveraging its proprietary platform to create grafts that enhance compatibility and reduce complications, thereby minimizing the need for frequent interventions and hospitalizations. Vessl Therapy's business model revolves around the research, development, and commercialization of these grafts, generating revenue through product sales to healthcare providers and institutions. The company aims to address the growing number of ESRD patients, driven by increasing prevalence of diabetes and hypertension, by offering a solution that extends the lifespan of synthetic grafts and reduces failure rates.

Source: Dealroom company data

At a glance

Status
Operational
Employees
1
Open positions
None listed
Dealroom signal
57.0/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

7 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VC✓Equity / VC Apr 2021 $16M $64M RunYoung Capital —
LATE VC✓Equity / VC Jan 2012 $0 — Undisclosed —
Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Growth signals

Vessl Therapeutics website traffic

Latest recorded traffic for Vessl Therapeutics is 370 monthly website visits, down 15.9% over the last three months. Vessl Therapeutics's team grew 0% over the past year.

Latest monthly visits370 3-month web change-15.9% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Vessl Therapeutics in the Yokneam Ilit ecosystem

Live from Dealroom

The Vessl Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later1 investor entered at this stage

  • RunYoung Capital

Other known investors2 additional known investors

  • Technion Israel Institute of Technology
  • XT Hi-Tech
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇮🇱 Israel100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Vessl Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Vessl Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.